Candriam SCA’s Janux Therapeutics JANX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-137,105	Closed	-$6.23M	–	691
2024 Q3	$6.23M	Buy	137,105 +25,101	+22%	+$1.14M	0.04%	326
2024 Q2	$4.69M	Buy	112,004 +31,999	+40%	+$1.34M	0.03%	348
2024 Q1	$3.01M	Buy	+80,005	New	+$3.01M	0.02%	436